Pinned Tweet
Over 85% of oncologists at Memorial Sloan Kettering Cancer Center use OpenEvidence.
Together, @MSKCancerCenter and OpenEvidence have built OncoKB, MSK’s expert interpretation of a tumor’s genetics, directly into OpenEvidence, putting it in the hands of oncologists across the United States.
As Dr. Anaeze Offodile puts it: “Our mission is to end cancer for life.” As of today, we are widening OncoKB’s reach so that patients everywhere benefit from the same rigor as patients at MSK. Watch the story.
OpenEvidence CMO @TravisZack2 was in the room for this. Thanks for having us, @WCMEmergency.
Technology should support the human relationships at the center of healthcare. We're grateful to the speakers, researchers and innovators who joined us our 9th Annual Virtual Healthcare Conference to advance that conversation. emed.weill.cornell.edu/news/…
11
960
OpenEvidence retweeted
We know Patients are using AI tools to get information about their health. At OpenEvidence, we have long talked about building a tool for patients with the same evidence engine clinician is using. Excited to study such a tool with Apple during this collab
Apple and OpenEvidence are launching a study based around an experimental AI-powered health chat app, hinting at possible new directions for both companies. trib.al/uohPaGF
OpenEvidence retweeted
From @WSJopinion: Doctors have a new assistant. OpenEvidence, an AI-powered platform, is helping physicians and saving lives, writes @andykessler.
on.wsj.com/3Vtaldy
OpenEvidence retweeted
BREAKING NEWS!
What a Monday morning! Apple and OpenEvidence just launched an experimental health chat app
The Apple Health AI Usage Study app was designed to answer health questions only using trusted medical research and based on your health metrics and records.
"The study will also explore how health AI can potentially help participants better prepare for clinical visits with their own doctors and will ask the user for feedback along the way about how the experience is going.
For example, someone asking how to improve their resting heart rate could receive advice based on their own health measurements, rather than general recommendations."
It's big news for both companies! Apple wants to use AI to help its users get the medical information and health insights they need, similarly to how ChatGPT launched ChatGPT Health and Anthropic launched Claude for healthcare.
OpenEvidence so far has been focusing on building AI for medical professionals and now turns towards general consumers too.
The question is whether this collaboration is going to mean enough trust for Apple users to share their health data and use the service.
If you are an Apple user, please share your thoughts!
Source: abcnews.com/US/apple-launche…
OpenEvidence retweeted
We are so thrilled about this partnership with @OpenEvidence, the physicians we'll be able to reach, and the impact we'll be able to make for patients!
Excited to work with Daniel Nadler and his team on this important mission!
The drug that saved @DavidFajgenbaum's life has been on pharmacy shelves for decades. It was approved for kidney transplants. He nearly died of Castleman disease and had been told there was nothing left to try.
Thousands of diseases have no FDA-approved treatment. For some of them, the answer may already be sitting in a pharmacy. Nobody has run the trial.
@EveryCure, the nonprofit he co-founded, exists to run these trial. Starting today, we’re working with them. OpenEvidence will help evaluate repurposing hypotheses, connect each program with the few physicians who actually treat the disease, and bring trial results back to the point of care when they land.
Many of these are generic drugs. No one has a commercial reason to study them. That is exactly why a nonprofit has to.
The drug that saved @DavidFajgenbaum's life has been on pharmacy shelves for decades. It was approved for kidney transplants. He nearly died of Castleman disease and had been told there was nothing left to try.
Thousands of diseases have no FDA-approved treatment. For some of them, the answer may already be sitting in a pharmacy. Nobody has run the trial.
@EveryCure, the nonprofit he co-founded, exists to run these trial. Starting today, we’re working with them. OpenEvidence will help evaluate repurposing hypotheses, connect each program with the few physicians who actually treat the disease, and bring trial results back to the point of care when they land.
Many of these are generic drugs. No one has a commercial reason to study them. That is exactly why a nonprofit has to.
When Every Cure’s programs reach trials, OpenEvidence will flag when a patient may qualify. The treating physician decides whether to refer. Read full announcement: businesswire.com/news/home/2…
“OpenEvidence is the most trusted and loved brand product among doctors. Apple is the most trusted and loved brand and product among consumers, and especially health consumers. So you have to bring these two things together. It’s like peanut butter and jelly.”
--OpenEvidence CEO Daniel Nadler
Apple and OpenEvidence are launching a study based around an experimental AI-powered health chat app, hinting at possible new directions for both companies. trib.al/uohPaGF
OpenEvidence retweeted
Apple Health AI x @OpenEvidence research study! apple.com/newsroom/2026/11/a…
In @WSJ, @andykessler explores how AI is supporting physicians and reshaping modern medicine. OpenEvidence mission remains simple: unburdening doctors with trusted, peer-reviewed evidence so they can stay focused on their patients.
wsj.com/opinion/doctors-have…
OpenEvidence retweeted
Guidelines tell us what to do with new data. They're much less help with the patient in clinic who never would have made it into the trial.
@OpenEvidence and the Uromigos are bringing expert opinion in to help with those gaps. It doesn't replace the guidelines 🤝. Look forward to see this roll out
#urovoices #uromigos
OpenEvidence retweeted
Thank you @OpenEvidence for quoting my perspective on the choice of systemic therapy in Thoracic Large Cell Neuroendocrine Tumors @OncoAlert @oncodaily @myESMO @ASCO @ASCOPost @IASLC
OpenEvidence retweeted
Taking a theoretical treatment plan and effectuating into practice implies taking cost into account! So proud of the team for this
A prescription the patient can't afford, or the payer won't approve, doesn't treat anything.
Today we launched Access Intelligence: copay savings, patient assistance, program enrollment, and prior authorization, inside OpenEvidence. Free for all clinicians.
The help exists. There are thousands of support programs, and prior auths can be won. But the work is scattered across payers and programs, each with its own forms and criteria, and you have a few minutes per patient.
What's live now:
* Ask about availability and eligibility across 2,500+ patient support programs, updated daily.
* Send copay savings and discount offers to the patient with Patient TakeHome.
* Download pre-populated enrollment forms, or enroll on OpenEvidence.
* Write prior auth requests, appeals, and letters of medical necessity grounded in clinical guidelines, with PA checklists and relevant ICD-10 codes.
Choosing the right treatment should be the hardest part of getting a patient treated.
OpenEvidence retweeted
While the end user of OpenEvidence is a clinician, everything we do is in service of providing those providers and, subsequently, their patients, with the resources they need to make informed decisions. Today, we take a big step into incorporating more resources beyond clinical evidence to support those decisions with Access Intelligence.
A prescription the patient can't afford, or the payer won't approve, doesn't treat anything.
Today we launched Access Intelligence: copay savings, patient assistance, program enrollment, and prior authorization, inside OpenEvidence. Free for all clinicians.
The help exists. There are thousands of support programs, and prior auths can be won. But the work is scattered across payers and programs, each with its own forms and criteria, and you have a few minutes per patient.
What's live now:
* Ask about availability and eligibility across 2,500+ patient support programs, updated daily.
* Send copay savings and discount offers to the patient with Patient TakeHome.
* Download pre-populated enrollment forms, or enroll on OpenEvidence.
* Write prior auth requests, appeals, and letters of medical necessity grounded in clinical guidelines, with PA checklists and relevant ICD-10 codes.
Choosing the right treatment should be the hardest part of getting a patient treated.
A prescription the patient can't afford, or the payer won't approve, doesn't treat anything.
Today we launched Access Intelligence: copay savings, patient assistance, program enrollment, and prior authorization, inside OpenEvidence. Free for all clinicians.
The help exists. There are thousands of support programs, and prior auths can be won. But the work is scattered across payers and programs, each with its own forms and criteria, and you have a few minutes per patient.
What's live now:
* Ask about availability and eligibility across 2,500+ patient support programs, updated daily.
* Send copay savings and discount offers to the patient with Patient TakeHome.
* Download pre-populated enrollment forms, or enroll on OpenEvidence.
* Write prior auth requests, appeals, and letters of medical necessity grounded in clinical guidelines, with PA checklists and relevant ICD-10 codes.
Choosing the right treatment should be the hardest part of getting a patient treated.
Full announcement: businesswire.com/news/home/2…
16
2,054
OpenEvidence retweeted
This was 1 year in the making. As we build life long education for physicians, excited for @ACPIMPhysicians to be a partner
ACP, the largest medical specialty organization in the US, and @OpenEvidence, the most popular AI for doctors in the United States, announce a collaboration to bring trusted, evidence-based clinical content to physicians at the point of care. OpenEvidence will license ACP’s evidence-based clinical guidance and published content from its peer-reviewed clinical journal, @AnnalsofIM, one of the world’s most widely cited and influential medical journals: bit.ly/48AP44B
OpenEvidence retweeted
ACP, the largest medical specialty organization in the US, and @OpenEvidence, the most popular AI for doctors in the United States, announce a collaboration to bring trusted, evidence-based clinical content to physicians at the point of care. OpenEvidence will license ACP’s evidence-based clinical guidance and published content from its peer-reviewed clinical journal, @AnnalsofIM, one of the world’s most widely cited and influential medical journals: bit.ly/48AP44B
The phrase "evidence-based medicine" first appeared in print in ACP Journal Club in 1991. Thirty-five years later, @ACPIMPhysicians's clinical guidance and Annals of Internal Medicine are coming into OpenEvidence.
Internal medicine is the largest specialty on OpenEvidence, and the questions span the whole chart. An internist can go from adjusting a heart failure regimen in one room to untangling a drug interaction in a patient on twelve medications in the next. The evidence has to keep up.
Both will be inside OpenEvidence, cited in the answer so the physician can check the source before acting on it.
Read full announcement prnewswire.com/news-releases…






















